Adverse Effects Associated With the Use of Antimalarials During The COVID-19 Pandemic in a Tertiary Care Center in Mexico City

• Main Authors: Oscar Arturo Lozano-Cruz (Author), José Víctor Jiménez (Author), Antonio Olivas-Martinez (Author), Edgar Ortiz-Brizuela (Author), José Luis Cárdenas-Fragoso (Author), Daniel Azamar-Llamas (Author), Sergio Rodríguez-Rodríguez (Author), Jorge Carlos Oseguera-Moguel (Author), Joel Dorantes-García (Author), Clemente Barrón-Magdaleno (Author), Aldo C Cázares-Diazleal (Author), Carla Marina Román-Montes (Author), Karla María Tamez-Torres (Author), Bernardo Alfonso Martínez-Guerra (Author), Alfonso Gulias-Herrero (Author), María Fernanda González-Lara (Author), Alfredo Ponce- (Author), David Kershenobich-Stalnikowitz (Author), José Sifuentes-Osornio (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Antimalarial drugs were widely used as experimental therapies against COVID-19 in the initial stages of the pandemic. Despite multiple randomized controlled trials demonstrating unfavorable outcomes in both efficacy and adverse effects, antimalarial drugs are still prescribed in developi...